RecruitingNot applicableNCT06767332
EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial
Studying Familial melanoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Leiden University Medical Center
- Principal Investigator
- Chris Hinnen, Dr.Leiden University Medical Centre
- Intervention
- eye movement desensitization and reprocessing (EMDR)(other)
- Enrollment
- 30 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2025
Study locations (2)
- Leiden University Medical Center, Leiden, South Holland, Netherlands
- Leiden University Medical Centre, Leiden, South Holland, Netherlands
Collaborators
Erasmus Medical Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06767332 on ClinicalTrials.govOther trials for Familial melanoma
Additional recruiting or active studies for the same condition.